118 related articles for article (PubMed ID: 9222304)
1. Effects of 1,25-dihydroxyvitamin D3 on tumor cell invasion to the extracellular matrix in human fibrosarcoma HT1080 cells and its correlation with laminin.
Yudoh K; Matsui H; Tsuji H
Tumour Biol; 1997; 18(2):69-79. PubMed ID: 9222304
[TBL] [Abstract][Full Text] [Related]
2. 1alpha,25-dihydroxyvitamin D3 inhibits in vitro invasiveness through the extracellular matrix and in vivo pulmonary metastasis of B16 mouse melanoma.
Yudoh K; Matsuno H; Kimura T
J Lab Clin Med; 1999 Feb; 133(2):120-8. PubMed ID: 9989763
[TBL] [Abstract][Full Text] [Related]
3. 1alpha,25-dihydroxyvitamin D3 and its analogues down-regulate cell invasion-associated proteases in cultured malignant cells.
Koli K; Keski-Oja J
Cell Growth Differ; 2000 Apr; 11(4):221-9. PubMed ID: 10775039
[TBL] [Abstract][Full Text] [Related]
4. 1 alpha,25-Dihydroxyvitamin D3 inhibits the invasive potential of human breast cancer cells in vitro.
Hansen CM; Frandsen TL; Brünner N; Binderup L
Clin Exp Metastasis; 1994 May; 12(3):195-202. PubMed ID: 8194194
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of laminin-binding integrins by 1 alpha,25-dihydroxyvitamin D3 in human melanoma cells in vitro.
Hansen CM; Madsen MW; Arensbak B; Skak-Nielsen T; Latini S; Binderup L
Cell Adhes Commun; 1998 Mar; 5(2):109-20. PubMed ID: 9638332
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of high and low laminin-adherent Dunn osteosarcoma cells selected by adhesiveness to laminin. Correlation between invasiveness through the extracellular matrix and pulmonary metastatic potential.
Yudoh K; Matsui H; Kanamori M; Ohmori K; Yasuda T; Tsuji H
Tumour Biol; 1996; 17(6):332-40. PubMed ID: 8938948
[TBL] [Abstract][Full Text] [Related]
7. Actions of vitamin D3, analogs on human prostate cancer cell lines: comparison with 1,25-dihydroxyvitamin D3.
Skowronski RJ; Peehl DM; Feldman D
Endocrinology; 1995 Jan; 136(1):20-6. PubMed ID: 7530193
[TBL] [Abstract][Full Text] [Related]
8. Tumor cell attachment to laminin promotes degradation of the extracellular matrix and cell migration in high-metastatic clone cells of RCT sarcoma in vitro.
Yudoh K; Matsui H; Kanamori M; Ohmori K; Tsuji H
Jpn J Cancer Res; 1995 Jul; 86(7):685-90. PubMed ID: 7559087
[TBL] [Abstract][Full Text] [Related]
9. Role of laminin-binding integrin in the invasion of basement membrane matrices by fibrosarcoma cells.
Ramos DM; Cheng YF; Kramer RH
Invasion Metastasis; 1991; 11(3):125-38. PubMed ID: 1938274
[TBL] [Abstract][Full Text] [Related]
10. Expression of laminin by human fibroblasts, HT1080 fibrosarcoma cells and MCF-7 breast adenocarcinoma cells. Lack of regulation by the cell density and extracellular matrix.
Munaut C; Noël A; Sobel M; Foidart JM
Cell Biol Int Rep; 1991 Jun; 15(6):499-509. PubMed ID: 1742797
[TBL] [Abstract][Full Text] [Related]
11. 1,25-Dihydroxyvitamin D3 decreases human prostate cancer cell adhesion and migration.
Sung V; Feldman D
Mol Cell Endocrinol; 2000 Jun; 164(1-2):133-43. PubMed ID: 11026565
[TBL] [Abstract][Full Text] [Related]
12. 1,25-dihydroxyvitamin D3 induction of nerve growth factor in L929 mouse fibroblasts: effect of vitamin D receptor regulation and potency of vitamin D3 analogs.
Musiol IM; Feldman D
Endocrinology; 1997 Jan; 138(1):12-8. PubMed ID: 8977379
[TBL] [Abstract][Full Text] [Related]
13. Liarozole acts synergistically with 1alpha,25-dihydroxyvitamin D3 to inhibit growth of DU 145 human prostate cancer cells by blocking 24-hydroxylase activity.
Ly LH; Zhao XY; Holloway L; Feldman D
Endocrinology; 1999 May; 140(5):2071-6. PubMed ID: 10218956
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of 1,25-dihydroxyvitamin D3 and tetradecanoylphorbol acetate on cell cycle and apoptosis of MCF-7 cells and a vitamin D3-resistant variant.
Narvaez CJ; Welsh J
Endocrinology; 1997 Nov; 138(11):4690-8. PubMed ID: 9348195
[TBL] [Abstract][Full Text] [Related]
15. The in vitro evaluation of 25-hydroxyvitamin D3 and 19-nor-1alpha,25-dihydroxyvitamin D2 as therapeutic agents for prostate cancer.
Chen TC; Schwartz GG; Burnstein KL; Lokeshwar BL; Holick MF
Clin Cancer Res; 2000 Mar; 6(3):901-8. PubMed ID: 10741714
[TBL] [Abstract][Full Text] [Related]
16. Evidence that both 1alpha,25-dihydroxyvitamin D3 and 24-hydroxylated D3 enhance human osteoblast differentiation and mineralization.
van Driel M; Koedam M; Buurman CJ; Roelse M; Weyts F; Chiba H; Uitterlinden AG; Pols HA; van Leeuwen JP
J Cell Biochem; 2006 Oct; 99(3):922-35. PubMed ID: 16741965
[TBL] [Abstract][Full Text] [Related]
17. The E1A oncogene induces resistance to the effects of 1,25-dihydroxyvitamin D3 on inhibition of growth of mouse keratinocytes.
Park K; Bae H; Heydemann A; Roberts AB; Dotto GP; Sporn MB; Kim SJ
Cancer Res; 1994 Dec; 54(23):6087-9. PubMed ID: 7954451
[TBL] [Abstract][Full Text] [Related]
18. 1,25-Dihydroxyvitamin D3 and pancreatic beta-cell function: vitamin D receptors, gene expression, and insulin secretion.
Lee S; Clark SA; Gill RK; Christakos S
Endocrinology; 1994 Apr; 134(4):1602-10. PubMed ID: 8137721
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of 1,25-dihydroxyvitamin D3 stimulated osteocalcin gene transcription by tumor necrosis factor-alpha: structural determinants within the vitamin D response element.
Kuno H; Kurian SM; Hendy GN; White J; deLuca HF; Evans CO; Nanes MS
Endocrinology; 1994 Jun; 134(6):2524-31. PubMed ID: 8194478
[TBL] [Abstract][Full Text] [Related]
20. Physiological and clinically attainable concentrations of 1,25-dihydroxyvitamin D3 suppress proliferation and extracellular matrix protein expression in mouse pancreatic stellate cells.
Bläuer M; Sand J; Laukkarinen J
Pancreatology; 2015; 15(4):366-71. PubMed ID: 26005021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
